Didier Dréau

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Kimia Kaffashi, Didier Dréau, Irina V Nesmelova
Heterodimers Are an Integral Component of Chemokine Signaling Repertoire. International journal of molecular sciences 24 (14) (2023)
Nicole L Stott Bond, Didier Dréau, Ian Marriott, Jeanette M Bennett, Michael J Turner, Susan T Arthur, Joseph S Marino
Low-Dose Metformin Treatment Reduces In Vitro Growth of the LL/2 Non-small Cell Lung Cancer Cell Line. Biomedicines 11 (1) (2022)
Nicole L Stott Bond, Didier Dréau, Ian Marriott, Jeanette M Bennett, Michael J Turner, Susan T Arthur, Joseph S Marino
Low-Dose Metformin Treatment Reduces In Vitro Growth of the LL/2 Non-small Cell Lung Cancer Cell Line. Biomedicines 11 (1) (2022)
Nicole L Stott Bond, Didier Dréau, Ian Marriott, Jeanette M Bennett, Michael J Turner, Susan T Arthur, Joseph S Marino
Low-Dose Metformin as a Monotherapy Does Not Reduce Non-Small-Cell Lung Cancer Tumor Burden in Mice. Biomedicines 9 (11) (2021)